Clinical Trials Directory

Trials / Completed

CompletedNCT02822911

Benefit of Carbohydrate Deficient Transferrin to Detect Chronic Alcohol Abuse in the Elderly

Benefit of Carbohydrate Deficient Transferrin to Detect Chronic Alcohol Abuse in the Elderly. A French Multicentered Prospective Interventional Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
194 (actual)
Sponsor
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

Alcohol misuse affects 5 million people in France. Even though the elderly are also concerned by this pathology, there is not much information about chronic alcohol misuse of this population in particular. Biological markers like gamma-glutamyltranspeptidase (GGT), mean corpuscular volume (MCV) and carbohydrate deficient transferrin (CDT) are usually used to detect alcohol abuse. As a biological marker of alcohol misuse, the specificity of the CDT is known to be superior to the GGT as well. However, when it comes to the elderly, alcoholism diagnosis tools are based on research of younger populations. This study aims to evaluate the benefit of the CDT to detect chronic alcohol use in the elderly.

Detailed description

Problematic alcohol misuse is frequent but tends to decrease with age. According to the French Alcohology Society, 10% of the adult population is alcohol abstinent and after 65 years old, they are 40% to abstain from alcohol. On the other hand, the French Alcohology Society also reports that a regular or daily alcohol consumption for older people increases the risk of dependence on alcohol. For the elderly, biological disorders can be related to polymedication or other conditions related to the aging process, making it difficult to diagnose alcoholism for aged people. For the study, the three-item Alcohol Use Disorders Identification Test (AUDIT-C) will be submitted to : * every patient admitted in the Hospital of Mulhouse (France) for at least a day in the Geriatrics Department * every patient entering the General Practitioner Support Association of Alsace, France (translated in French as the "RAG"). When the score of the AUDIT-C reaches at least 1 point, the study will collect results of the GGT and MCV performed as routine practice and add the CDT in the blood tests.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAlcohol Used Disorders Identification Test (AUDIT C)The Audit-C questionnaire is a three item alcohol screen that can help identify persons who are hazardous drinkers or have active alcohol abuse disorders (including alcohol abuse or dependence). The AUDIT-C is a modified version of the 10 question AUDIT instrument. Score from 0 to 12. Each Audit-C question has a 5 answer choice, allotted points are from 0 to 4 points. In men, a score of 4 is considered as positive, optimal for identifying hazardous users or active alcohol abuse disorders. The same for 3 points in women.
PROCEDURECarbohydrate deficient transferrinBlood sample to collect carbohydrate deficient transferrin (CDT) only if the Alcohol Used Disorders Identification Test (AUDIT C) reports at least 1 point.
PROCEDUREGamma glutamyl transpeptidaseResults of Gamma glutamyl transpeptidase (GGT) performed as routine practice collected only if the Alcohol Used Disorders Identification Test (AUDIT C) reaches at least 1 point.
PROCEDUREMean Corpuscular VolumeResults of Mean Corpuscular Volume (MCV) performed as routine practice collected only if the Alcohol Used Disorders Identification Test (AUDIT C) reports at least 1 point.

Timeline

Start date
2016-03-01
Primary completion
2016-10-01
Completion
2016-10-01
First posted
2016-07-06
Last updated
2025-11-20

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02822911. Inclusion in this directory is not an endorsement.

Benefit of Carbohydrate Deficient Transferrin to Detect Chronic Alcohol Abuse in the Elderly (NCT02822911) · Clinical Trials Directory